Press Release August 22, 2023 Empowering Transformation: Kiola Raines’ Journey to Fitness Excellence with M2 ProDesign
Press Release August 22, 2023 Hyperphosphatemia Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Shield Therapeutics, Kyowa Kirin Co., Ltd., Bayer, Kissei Pharma, Alebun
Press Release August 22, 2023 Hemophilia Pipeline Report, 2023 Updates: In-depth Analysis into the Clinical Trials, Latest FDA, EMA, and PMDA Approvals, Emerging Drugs, and Growth Prospects | Poseida Therapeutics, Biopharma Crp.
Press Release August 22, 2023 Triple Negative Breast Cancer (TNBC) Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | HiberCell, Hoffmann-La Roche, Infinity Pharma, CytoDyn
Press Release August 22, 2023 Wet Age-Related Macular Degeneration Pipeline and Clinical Trials Assessment 2023: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Shanghai Biomabs Pharma, Ocular, RemeGen, Ribom
Press Release August 22, 2023 Epilepsy Pipeline Drugs Analysis Report, 2023: FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration by DelveInsight | SK Biopharmaceuticals, Receptor Life Sciences
Press Release August 22, 2023 Extensive-Stage Small Cell Lung Cancer (ESCLC) Pipeline Review | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, Clinical Trials, and Treatment Outlook | CSPC ZhongQi Pharma, Akeso
Press Release August 22, 2023 Propulsion of PCSK9 Inhibitor Clinical Trial Pipeline as Novel and Extensive 14+ Therapies Likely to Enter in the Domain | DelveInsight
Press Release August 22, 2023 Propulsion of Hyperphosphatemia Clinical Trial Pipeline as Novel and Extensive 15+ Therapies Likely to Enter in the Domain | DelveInsight
Press Release August 22, 2023 Janet Hixson Presents Mrs. Tourism USA – Empowering Women, Advocating Against Domestic Violence, and Promoting Tourism